I thought this would be interesting for Qbiotics shareholders...https://www.biospace.com/business/boehringer-buys-nerio-therapeutics-for-1-3b-to-boost-immuno-oncology-pipeline
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
